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In the preceding paper  (1)  the process through which the MEF1  strain of 
Lansing-type poliomyelitis virus was adapted  to  newborn mice has been de- 
scribed.  In a  previous publication (2)  a  complement-fixing antigen obtained 
with the newborn mouse-adapted strain was reported. It is the purpose of the 
present paper to describe in more detail the complement-fixation (CF) test for 
infection with poliomyelitis virus and to report the results of tests with sera 
from  several animal species,  including man. 
Materials and Methods 
Vbus.--The MEF1 strain (3) of Lansing-type poliomyehfis virus adapted to newborn mice, 
designated hereafter  the adapted  strain,  was used throughout  for the preparation  of polio- 
myelitis antigen and mouse hyperimmune serum. The MEF1 standard  strain, that is to say, 
the one which is being propagated currently in the laboratory and passaged only in adult mice 
and the stock Lansing strain (Armstrong (4)) were employed for the Dret~aration  of immune 
sera in other species, and for neutralization tests. 
The Nakayama strain of Japanese B encephahtis virus (J.B.E.) and the McMillan strain 
(5) of Western equine encephalitis virus (W.E.E.) were employed for the preparation of control 
antigens and immune sera. The J.B.E.  virus had an unknown but large number of mouse 
passages; the W.E.E.,  from 6 to 10. 
Antigen.--The material from which the MEF1 antigen was prepared consisted of brain and 
spinal cord tissue deriving from newborn mice. 3- and 4-day-old mice were inoculated intra- 
cerebrally with 0.02 ml. of a 10  -1 dilution of the adapted virus. If 10  "a dilutionwas injected the 
result was a delayed incubation period. When the mice first became paralyzed, on the 2nd, 
3rd, or 4th day following inoculation, they were exsanguinated  a and the relatively blood-free 
central nervous system (CNS) tissue was harvested by means of an incision of the cranium 
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1  All such operations were carried out with the aid of deep ether anesthesia. 
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and spinal column thus exposing the tissues. It was later found that the more potent antizens 
were prepared from material collected on the 2nd day after inoculation; perhar~s a still earlier 
period might yield better results--a matter now being investigated. The tissne~ were immedi- 
ately frozen by placing them in a dish in a solid CO2 alcohol bath and the pooled tissues from 
a number of mice were kept frozen at --20°C. until ready for use. This procedure was followed 
since harvested tissues held at room temperature for periods of about 1 hour softened rapidly 
and did not yield effective antigens. 
Active antigens were first prepared with CNS of the 21st mouse passage of the adapted 
virus; no previous passage had been tested. From the 21st passage to the present 70th. usable 
antigens have been secured consistently. 
20 to 25 gin. of tissue obtained from 80 to 100 mice sufficed for a single preparation of anti- 
gen. It was produced by a method previously described, (6), carried out as follows :- 
The tissues were thawed,  then homogenized, and rapidly extracted with 20 volumes of 
chilled acetone in an ice-packed Waring blendor. Following centrifugation the sediment was 
reextracted with acetone, once with a mixture of equal parts of acetone and anhydrous ethyl 
ether, and twice more with ether. Each of these successive extractions was allowed to  proceed 
for 20 minutes during which time the bottle containing the material was held in an ice bath. 
After the last ether extraction, the residual ether was evaporated under an oil pump vacuum. 
The dry residue was then resuspended in physiological saline solution, the proportion used 
being 1 ml. of saline solution for each gram of wet tissue weight. The material was shaken by 
hand a  few times, kept at 4°C. overnight, and centrifuged at 10,500  R.p.x¢. for 1 hour in an 
electrically driven angle head centrifuge. The supernatant fluid which constituted the antigen 
was pipetted off, merthiolate in final dilution of 1 : 10,000 added, and the antigen kept frozen 
at  --20°C.  The average yield of antigen was 0.6 ml. per gm. of tissue and  its appearance 
slightly opalescent. 
An identical procedure was followed for the preparation of control antigens from normal 
looking mice or from mice injected with J.B.E. or W.E.E.  viruses. For those obtained from 
normal, uninfected mice, the CNS of animals S to 8 days old were used. When antigens were 
prepared with J.B.E. and W.E.E. viruses, the mice were 3 or 4 days old when injected with 
the former and 4 to 6 days old with the latter. The two control viruses were not propagated 
serially in newborn mice, but were derived from suspensions of the standard virus propagated 
in 3- to 4-week-old animals. Cord and brain tissue were harvested on the 4th day after in- 
jection of J.B.E. virus and on the 2nd day following injection of W.E.E. virus, at which times 
the inoculated mice showed signs of active infection. 
Sera.--Sera from the following animal species have been tested: mouse, cotton rat, rhesus 
monkey,  chimpanzee,  and  man. 
Mou,  v.--Hyperimmune sera were prepared with the MEFl-adapted  strain, J.B.E.,  and 
W.E.E.  viruses. The procedure of immunization was as follows:-- 
A 10  -I suspension of brain and cord tissues from newborn mice infected with the respective 
virus was prepared in saline solution. Groups of 25 mice, 45 to 60 days old, were immunized 
by intraperitoneal injection of 0.S ml. of this suspension three times at 7 day intervals. 10 to 
12 days following the last treatment, the mice were bled from the heart under ether anesthesia. 
CF  antibody was  usually  present at  that  time;  if  not,  an additional injection  or two  of 
virus was  given and  the  mice bled again  10 to 12 days after the last dose.  They  could be 
reinjected and bled six or seven times at reasonable intervals for an ample supply of immune 
sera. With J.B.E. and W.E.E. viruses, however, the mice were given 2 intraperitoneal injec- 
tions of formalin-inactivated virus on the 8th and 10th day prior to the first inoculation of ac- 
tive virus, each dose being 0.25 ml. of a  10-' suspension. This was done in order to prevent 
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Cotton Rat.--Cotton rat hyperimmune sera after being kept frozen for over i  year have 
been found to contain specific CF antibody. The available sera were derived from a group of 
13 cotton rats which had been immunized as follows:- 
Mouse passage Armstrong strain was transmitted four times serially in cotton rats; brain 
and cord from passages 3 and 4, in a 10  -t suspension, were given intramuscularly, 0.5 ml. into 
each thigh, and 23 days later the rats were bled, the bloods pooled, and the serum kept frozen. 
52, 74, and 81 days after the first injection, they were reinjected intraperitoneally with 2 ml. 
of a similar suspension; 10 days after the last injection, or 91 days from the beginning of im- 
munization, the animals were bled again and the sera likewise stored at -20°C. The two pools 
of immune sera including several samples of sera derived from the same animals prior to im- 
munization, were available for the CF tests. The particular interest in the former is that they 
were prepared with a strain of Lansing virus different from the MEF1. 
Monkey.--Twenty-six different samples of rhesus monkey sera were available. Of these, 10 
were paired sera from 5 animals; 14 were single samples from individual monkeys and 2 were 
pooled specimens from normal animals. The previous course of events in the monkeys is set 
down in Table IV. It will be noted that the animals were injected, or immunized, or convales- 
cent from infection with the following strains of poliomyelitis virus: MEF1 and Armstrong, 
both Lansing type, as already stated; MV, also a  Lansing type; Brunhilde, a  non-Lansing 
virus;  and  Leon,  also  a  non-Lansing  virus,  but  serologically  unrelated  to  the  Brun- 
hilde strain  (7). 
Chimpanzee.--Serial bleedings of 5 chimpanzees which received poliomyelitis virus orally 
were available. One of them, "Rosebud," was fed a non-Lansing-type virus (Pittsfield strain) 
first and a  Lansing type  (YSK)  later. The other 4 were first fed YSK virus and later the 
Brunhilde. Detailed accounts of the sequence of events are shown in Table V. 
Man.--Sera from 76 individuals were tested both by neutralization and CF methods. Of 
these,  41  were  apparently normal individuals with no history of poliomyelitis; they were 
designated controls and 35 were persons recently attacked by poliomyelitis. Among the latter, 
a number supplied serial sera; another group contributed paired sera, and the remainder had 
been bled only once, during convalescence. The results of the neutralization tests were given 
by the laboratories which supplied the sera, or were determined in this laboratory. Further- 
more, when paired or serial sera were tested, only the result of the CF and neutralization testa 
on  one  sample will be discussed here; the question of the development of CF antibody with 
time and its possible practical use as a diagnostic test is to be taken up in another publication. 
All sera, human and  animal, were inactivated at 60"C. for 20 minutes for the CF test (8) 
and  at 56°C. for 30 minutes for neutralization, following the routine procedure of this  labo- 
ratory. 
Hemolytic System.--Commerclaliy  available sheep erythrocytes and antlsheep hemolysin 
were used. The former, a stabilized suspension of washed and pooled cells, was prepared as a 
3  per cent suspension and the hemolysin was diluted adequately so as to have 3  minimal 
hemolytic doses in the required volume. Cells and hemolysin were mixed and held at room 
temperature for 15 minutes before they were added to the other materials of a  test. 
Complement.--Fresh guinea pig serum was used occasionally as complement; ordinarily, 
however, a commercially"  available lyophylized preparation was employed. The latter had the 
advantage of a fairly constant strength, thereby insuring greater uniformity in the tests. The 
titers of the antigens were generally low; moreover, the antigens showed occasionally an en- 
hancement of hemolysis by complement. Under these conditions an excess complement was 
likely to result in incomplete fixation or yield low readings. For these reasons it was found 
necessary to titrate the complement accurately and to add in the test no less than 1.6 units 
and no more than 2 units of complement, preferably, 1.8 units. Physiological saline solution, 126  COMPLEMENT  ]HXATION IN POLIOMYELITIS 
0.85 per cent sodium chloride, was the diluent not only of complement but of all the materials 
of the test. Because of its importance, the titration of complement will be described here in 
detail. 
Rehydrated lyophilized complement was diluted 1:29 in saline solution designated as orig- 
inal dilution of  complement; adequate  amounts of this dilution and of saline solution were 
placed in a set of 8 master test tubes, to produce a graduated series containing 0.16, 0.14, 0.12, 
0.10, 0.08, 0.07, 0.06, and 0.04 ml. of the original dilution in each 0.3 ml. From these master 
tubes 0.3 ml. of each dilution was transferred to selected test tubes, 13  X  100 mm. To each 
tube  of the  latter series 0.2 ml. of saline solution was added,  then 0.2 ml. of the cells plus 
hemolysin. Mter incubation  at 37°C.  for 30 minutes,  the reaction was  read;  the smallest 
amount of complement giving complete hemolysis constituted one unit. The dilutions had 
been so calculated that ordinarily the unit of complement was 0.10 ml; therefore, in the test 
0.18 ml. had to be added which was equivalent to 1.8 units. 
The titration just described was the preliminary titration of complement; it indicated the 
amount to be used in the test. However, the true potency of the complement, as well as the 
anticomplementary power of the antigens, was determined in a second or final titration which 
was run along with the test proper in the following manner :- 
One set of tubes for each antigen to be tested and an additional set for control, i.e. without 
antigen, were prepared. 0.3 ml. of the mixture in the master tubes was delivered in succession 
to each tube in each set, thus affording several series containing from 0.16 ml. to 0.04 ml. of 
complement, as just described. To each of the tubes of the first set, the saline solution con- 
trols, 0.2 ml. of saline solution was added; to the tubes in the next set, 0.2 ml. of an antigen 
to be tested, continuing in this way until all the antigens of the test were added to their own 
row of tubes. These sets, which, in effect, constituted a titration of complement in the presence 
of each antigen along with a  saline control of complement, and the tubes of the test itself, 
were  placed  in the refrigerator at 4°C. for 18 hours. After this incubation and 30 minutes at 
room temperature the cells plus hemolysin were added and following incubation in the water 
bath for 30  minutes at 37°C., the test was read. By this procedure, the amount of free com- 
plement was determined in the presence of each antigen at the time when the cells plus hemo- 
lysin were added to the test proper. This procedure would show up any possible anticomple- 
mentary behavior of  the  antigens. 
No loss of complement activity under the conditions described has been observed; on the 
contrary, the titer of complement in the presence of the antigens was often higher than it had 
been in the preliminary titration. As a  result, the amount of free complement at the end of 
incubation in the first or fixation phase was, as a rule, between 1.8 and 2.0 units. 
Table I  illustrates the result of a typical titration of complement. Since experience showed 
that hemolytic or anticomplementary effect of the antigens could not be revealed in prelim- 
inary titrations they were consequently omitted. In the example tabulated, the unit of com- 
plement was contained in 0.10 ml.; 0.18 ml. was therefore used in the test. The final titration 
indicated that 1.8 unitsof complement were free in the presence of MEF1 and 3.B.E.  antigens 
as well as in the control having no antigen, and that 1.5 units were free with W.E.E. antigen. 
Test.--All sera were tested with two control antigens along with the MEF1 antigen,  and 
in addition, for anticomplementary power, i.e., in the absence of an antigen. Serial dilutions 
of serum were prepared, beginning with dilution 1:2 and carrying them up to 1:32 or 1:64. 
0.1 mh of each dilution was delivered into the test tubes, of which there were 4 sets, one having 
no antigen;  another, MEF1; a  third, J.B.E.; and the last, W.E.E. antigen. Next, 0.2 mh of 
the corresponding antigen was added, or in the control, 0.2 ml. of saline solution. The ade- 
quate amount of complement as determined by the preliminary titration was then introduced 
and the volume in the tubes was adjusted to 0.5 ml. with saline solution. The tubes containing j.  CASALS  7 P.  K.  OLITSKYy AND  R.  O.  ANSLOW  127 
serum, antigen, and complement in a volume of 0.5 ml. were held at 4°C. for  18  hours, after 
which at room temperature for 30 minutes. Then were added 0.1 ml. of a 3 per cent suspension 
of sheep cells and 0.1 ml. of hemolysin diluted so as to have 3 minimal hemolytic doses. The 
tubes now contained a final volume of 0.7 ml. and were incubated in a water bath at  37°C. 
for30 minutes. The reaction was read visually, 4+  representing no hemolysis and 0, complete 
hemolysis. A positive titer was defined as the highest dilution of serum giving a 2+ or  better 
fixation. 
TABLE  I 
Titration of Complement 
Rehydrated lyophylized complement diluted 1:29 
Antigen* 
None, saline 
MEFI 
J.B.E. 
W.E.E. 
Preliminary  [I  Final 
Amount of diluted complement,  ml. 
0.16 0.14 0.12 0.I0 0.08 0.07 0.06 0.04 ~  0.16 0.14 0.12  0.I0 0.08 0.07 0.06 
i 
* J.B.E., Japanese B encephalitis; W.E.E., Western equine encephalomyelitis. 
TABLE  II 
Titralions  of MEFI Antigen~  with ttyperimmune  MEF1 Mouse Serum 
Serm~ 
dilution  W.~...E. 
1 
Brain and cord, A  Antigen in dilutions 
Brain, B  Cord,  B  _  J.B.E. 
1  ~__~  1  2  ,  8  16  1  __ 
4  4  1  0  4  4  2  414  4  ±]olo 
4  4  0  0  ~  4  0  0  4t  4  3  0  I  ol  0 
4  s,  0  0  41  4  i  0  4  /  41  21  o  Lo  t  0  4  3  0  0  ~  4  0  414  3  0  I  ol  0 
4* 
8 
16 
32 
4*, 1"  =  dilution factors of serum or antigens. 
Table II  shows  the result of "box" titrations  of 3 MEF1 antigens and mouse hyperimmune 
serum and the way such a test is carried out. Antigen A was the regular antigen derived from 
pooled cord and brain tissue; its fiter was 1:2. Antigens B were derived from the same ani- 
mals by harvesting, on one hand, the cord and brain stem and, on the other, the rest of the 
brain tissue. The titer of the antigen made from cord and brain stem was 1:4, that of the one 
prepared from brain was 1 : 2 to 1:4. The titer of the serum used in this test was at least 1:32, 
for no further dilutions were tested. No reaction whatever took place with the J.B.E. and 
W.E.E. antigens prepared from brain and cord infected with the corresponding virus. 
Neutralization  Test.--The neutralizing antibody of the Lansing type was disclosed by the 
method already described (8-10), the test being performed either with the Armstrong, or the 
standard  MEF1 strain, and with dilutions of virus or dilutions of serum. 128  COMPLEMENT  FIXATION IN POLIOMYELITIS 
EXPERIM~ENTAL 
Specificity of the  Test.--An  antigen prepared  with  MEF1  virus adapted  to 
newborn mice and a technique for its use in a complement-fixation test to detect 
infection with a poliomyelitis virus were devised by application of the methods 
just described. Now the prime question was whether such an antigen and tech- 
nique were specific for poliomyelitis virus, at least for the homologous Lansing- 
type strains.  This question was answered by the results of repeated  tests with 
Lansing-type hyperimmune mouse and cotton rat sera and with sera obtained 
from  convalescent  and  immunized  monkeys,  as  will  be  noted  in  Tables  II 
to IV. 
TABLE III 
Complement-Fixation  Tests  with  Immune  Sera from  Various  Species  and  the MEF1  Virus 
Serum 
None 
Mouse, MEF1 ......................  0 
"  ,Japanese B ..................  0 
' '  , Western equine ..............  0 
Cotton rat, Armstrong ...............  ,  0 
Monkey 1108, MEF1 ................  I  0 
' '  19, Armstrong .............  ~]  0 
'  '  16,  Brunhilde ..............  ]  0 
Antigens 
MEF1  Japanese B  Western equine 
641~ 
0 
0 
64 
8 
16 
2 
0 
128+ 
0 
0 
0 
0 
0 
0 
128+ 
0 
0 
0 
0 
* 64  =  reciprocal of highest  dilution  of serum giving a  2+  or better fixation; 0  =  no 
fixation in 1:2 dilution of serum. 
In Table  II will  be  seen  that  complement fixation  occurred  only with  an 
antigen  prepared  from MEF1  infected  tissues,  even  though  the  Japanese  B 
and Western equine encephalitis virus antigens added as controls were made in 
precisely similar ways as was the MEF1 preparation.  The mouse serum, more- 
over, was shown to have antibody by means of a  neutralization  test for it neu- 
tralized  100,  or more, LDs0 of Lansing-type viruses,  i.e.,  to the possible limit 
of the  test.  It is also interesting  to note  that  the MEF1  antigen made from 
spinal cord tissue alone exhibited a  greater power of fixation than did the ones 
prepared from brain or from brain plus cord. 
In Table III will be observed again that cotton rat and mouse Lansing-type 
hyperimmune  sera  in  dilutions  of  1:64  fixed  complement  specifically by the 
MEF1  antigen and not by those highly potent heterologous ones of Japanese 
B  and Western  equine encephalitis viruses.  Additional evidence in Tables III 
and  IV is  brought  forward  to  demonstrate  that  not only was hyperimmune 
serum  obtained  from  the  mouse  and  cotton  rat  positive  but  also  from 
monkeys artificially  immunized  against  poliomyelitis  virus  and  convalescent 
from experimental poliomyelitis infection. Finally, one can see from these tab- j.  CASALS, P.  K.  0LITSKY, AND R.  O.  ANSLOW  129 
utated  results a  certain  even  though  slight  degree of  cross-reaction  between 
the MEF1 or Lansing type and the Brunhilde, a matter which will be discussed 
later. 
TABLE IV 
CompIemenI-Fixation Tests with Monkey Sera 
Lab. 
No. 
1 
2 
3 
8 
1108 
1109 
19 
20 
178 
179 
7 
16 
17 
18 
170 
171 
172 
173 
174 
175 
176 
177 
3711 
4 
15 
4889 
Designation 
of $era 
E483 
D95 
MV  D586 
K1816 
1108 
1109 
A1519 
A1503 
2275a 
"  b 
K3178 
A1329 
A1322 
A1325 
A215a 
"  b 
B216a 
"  b 
C225a 
"  b 
E207a 
~'  b 
3711 
NMS  B8 
Pool 2 
4889 
Animal con- I 
valescent  [ 
(C), immu- [ 
nized (I), or 
normal (N) 
Length of 
time  from 
onset in 
convales- 
cents 
days 
I 
I 
I 
I 
C  162 
C  92 
C  41 
C  41 
C  2 
C  26 
C  ? 
C  64 
i  C  68 
C  67 
C  0 
C  21 
C  0 
C  20 
C  1 
C  20 
C  2 
C  19 
C  241 
N 
N 
N 
Strain 
Leon 
Brunhilde 
MV 
Lansing 
MEF1 
~4 
Lansing 
~4 
14 
~4 
Minnesota 
Brunhilde 
~4 
~4 
~4 
4~ 
lC 
~4 
44 
~C 
4g 
4g 
MEFI 
0 
0 
8 
8 
16 
16 
16 
2 
0 
0 
16 
2 
0 
0 
0 
2 
0 
0 
0 
0 
0 
0 
8 
0 
0 
0 
CF  antigen 
Nor-  J.B.E.W.E.E.  mM  None 
0  0  0 
0  0  0 
0  0  0 
0  0 
0  2  0  0 
0 
0  0 
0  0 
0  0  0 
0  0  0 
4  0 
0  0 
0  O, 
0  0 
0  0  0 
2  2  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
0  0 
0  0 
It would thus appear from these repeated results that the complement-fixa- 
tion  test  depending  on  the  use  of MEF1  virus  antigen  and  immune  serum 
deriving from  mice,  cotton  rats,  and  monkeys  is  specific. Now  that  specific 
means for detection of an  immune antibody were at hand,  the next step was 
to determine how complement fixation could be used  to detect antibody in a 
number of monkey,  chimpanzee,  and human  sera which were then available. 
Monkey Sera.--The  results of  the  tests with  26  samples  of monkey serum 
are  shown  in  Table IV.  While the  specificity of the  reaction was  dearly  ap- 130  COMPLEMENT  FIXATION  IN  POLIOMYELITIS 
parent,  now and  again a  non-specific reaction occurred (Nos.  7 and  171)  as 
one might expect in a series of tests. Such odd results could be easily detected 
and interpreted through the use of control antigens, as was done here.  It will 
be observed that with immune sera, only the sera  from  animals  immunized 
with the Lansing type, including the serologically related MV strain, reacted 
with the MEF1 antigen.  Convalescent sera from monkeys injected with  Lan- 
sing  type  gave  positive  reactions when  the  animals  were  bled 41  days  or 
longer after onset of  paralysis, while no reaction occurred with  the serum of 
an animal bled on the 26th  day  after  onset. 
With respect  to the  possibility of a  cross-reaction occurring between  Lan- 
sing-type and non-Lansing-type viruses,  sera  from convalescent monkeys in- 
fected with the Brunhilde strain were negative in all cases bled within 68 days 
after onset. The reaction shown by serum  7 was non-specific and that given 
by serum 16 had too low a  titer to be significant. On the other hand,  serum 
3711  showed repeatedly a  positive reaction. This serum was obtained from a 
monkey which had  no Lansing-neutralizing antibody and  was  injected with 
MEF6 virus, known not to be a Lansing type (3), and the animal was bled 241 
days after onset. A  suggestion appeared here of a  cross-reaction between the 
MEF1  antigen and  a  non-Lansing  type-convalescent serum.  Moreover, this 
occurred in an animal bled 241  days after onset, while monkey 179 injected 
with Lansing-type virus was negative when bled only 26 days after onset. The 
problem which is left for further study is the time after onset of iUness when 
a  positive complement fixation can be secured. 
Chimpanzee Sera.--Serial bleedings from 5 chimpanzees were generously sup- 
plied by Dr. Melnick, who also provided the data reported in Table V on the 
type of virus given orally, the time of bleeding,  and  the results of the neu- 
tralization  tests.  As  shown in  the table  the animals  developed complement- 
fixing antibody against the MEF1 virus when first given YSK strain (a Lansing 
type) and later, Brunhilde virus. Again the specificity of the test is here demon- 
strated,  although  the  problem  of cross-reaction between Lansing  and  non- 
Lansing types could not  be resolved because  of  the  lack  of  an  orderly se- 
quence in feeding both types of virus. Chimpanzee Rosebud, however, which 
received a  non-Lansing virus first,  failed  to react with MEF1  antigen.  The 
positive reaction here with Japanese B encephalitis virus antigen was specific 
since the animal had been previously exposed to this virus. 
Human Sera.--Human sera were also studied  to disclose  (a)  whether man 
develops  specific  complement-fixing antibody  against  MEF1  virus  and  (b) 
whether any evidence can be deduced to detect cross-fixation between Lansing 
and non-Lansing types of poliomyelitis virus. Other studies, e.g. development 
of the antibody with time and in different clinical types of the disease, as well 
as the possibility of using this test for diagnosis of an early stage of poliomye- 
litis  are  still  being  carried  on. j.  CASALS,  P.  K,  OLITSKY~ AND  R.  O.  ANSLOW 
TABLE V 
Complement-Fixation Tests with Chimpanzee Sera 
Poliomyelitis virus given orally (Dr. Melnick's series) 
131 
Lab. 
No. 
89 
90 
84 
110 
165 
164 
83 
169 
105 
167 
108 
102 
87 
86 
101 
88 
Animal 
Rosebud 
21 
22 
23 
24 
Date of bleeding 
(B),  or viral 
exposure (V) 
3-10-47  B 
3-12-47  V 
%3147  B 
1-1348  B 
1-16-48  V 
6-1548  B 
8-15-50  B 
8-16-50  V 
10-4-50  B 
11-4-50  B 
11-14-50  V 
12-13-50  B 
8-15-50  B 
8-16-50  V 
10-4-50  B 
11-4-50  B 
11-14-50  V 
12-13-50  B 
8-15-50  B 
8-16-50  V 
10-4-50  B 
114-50  B 
11-14-50  V 
12-13-50  B 
Strain and length of 
time from viral 
exposure 
days 
--2 
Pittsfield 
140 
300 
YSK 
450 Pittsfield 
150  YSK 
--1 
YSK 
49 
80 
Brunhilde 
119  YSK 
29 Brunhilde 
--1 
YSK 
49 
80 
Brunhilde 
119  YSK 
29 Brunhilde 
--1 
YSK 
49 
80 
Brunhilde 
119  YSK 
29 Brunhilde 
8-15-50  B 
8-16-50  V 
10-4-50  B 
114-50  B 
11-14-50  V 
12-13-50  B 
--1 
YSK 
49 
80 
Brunhilde 
119  YSK 
29 Brunhilde 
Neutral-  CF antigen 
ization 
ts. Lans-  o 
ingvirus  MEF1  IJ.B.E.W.E.E.  Nor-  o  ~  real  I 
0  0  0  0 
0  0  0 
0  0  8  0 
1 : 550  0  8  0 
1:10 
0  0  0  0 
0  0  0  0 
2  0  0  0 
>1:100 
>1:100 
0  0  0  0 
2-4  0  0  0 
32  0  0  0 
0  0  0  0 
4-8  0  0  0 
4-8  0  0  0 
>1:100 
0  0 
0  0 
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That human sera reacted specifically with the MEF1 antigen is demonstrated 
in Tables VI and VII. In both one notes that positive reactions occurred only 
with MEF1 antigen; no fixation whatever or of any significant degree was ob- 
served with Japanese B  or Western equine encephalitis antigens. 
TABLE  VI 
Corn olement-Fixation  Tests with Human Sera 
Serum 
Poliomyelitis  convalescent 
Child  22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
182 
184 
"Normal" 
Adult  46 
47 
48 
49 
50 
51 
52 
53 
55 
56 
58 
60 
Neutraliz~tion in- 
dex for Lansing- 
virus 
>80 
5 
<  4 
4 
16 
4 
4 
10 
>  80 
4 
12 
I0 
>100 
100 
>300 
>100 
>300 
>100 
>100 
> 100 
>100 
>300 
>300 
>100 
Antigens 
None 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
MEFI 
16" 
2 
32+ 
32+ 
32+ 
2 
16 
0 
2 
16 
16 
64 
8 
0 
0 
0 
16 
8 
0 
0 
0 
4 
4 
4 
,~e  ~  Western 
equine 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
O 
0 
0 
O 
0 
0 
0 
0 
0 
* 16  =  reciprocal of highest dilution of serum giving a  2+ or better fixation; 0  =  no 
fixation in 1:2 dilution of serum. 
In Table VI will be seen the results of tests with sera from 12 children, aged 
1  to 9  years,  obtained some time during convalescence from paralytic polio- 
myelitis. The isolation of virus was not attempted and its type therefore not 
known. Since 10  of the cases exhibited negative or questionable neutralizing 
antibody against the Lansing virus, it was reasonable, and conformable with 
epidemiological practice, to assume that the epidemic occurring in New York ~.  CASALS,  P.  K,  OLITSKY,  AND  R.  O.  ANSLOW  133 
in  1950, from which the present patients were selected was not caused by a 
Lansing-type virus. As the table reveals, complement-fixing antibody was de- 
tected in high titer in a  number of instances. By the way of contrast, of 19 
children of similar ages, having no Lansing-neutralizing antibody and no his- 
tory of an attack by poliomyelitis, the serum of only one showed positive com- 
plement fixation with the MEF1  antigen. 
Table VI also summarizes the results of a  test with 12 sera from adult in- 
dividuals, aged  20  years or older,  who were apparently normal and had no 
TABLE  VII 
Complement-Fixation Tests on Sera from Poliomyelitis Cases 
Lansing-virus neutralization tests negative 
Age  Lab. 
No. 
81 
79 
72 
23 
27 
28 
31 
24 
25 
184 
N~e 
9  Wa. 
37  Gr. 
120  Be. 
76  Ho. 
Ri. 
Ob. 
Fi. 
M.P. 
D.E. 
J,J. 
K,L. 
M.M. 
E.R. 
Ha. 
D/agnosis 
y¢8. 
? 
? 
4 
1.5 
3 
8 
4 
6 
6 
5 
4.5I 
1.8  L 
2  I 
Le~ o~ 
l 
? 
Paralytic 
? 
Non- 
paralytic 
Paralytic 
type as reported 
Brunhilde ? 
~c 
Not reported 
Brunhilde- 
like 
Cc 
Not reported 
Cc  ~ 
CF &nt~en 
J.B.E.  W E  No~,  ~'~EFi  I~." 
4""  --I--10  O  -- 
4  0  0  { 
2 
2  0  0 
8  0  0 
8  0  2 
8  0  0 
2  0  0 
2  0  0 
32  0  0 
16  0  0 
32  0  0 
32  0  0 
64  0  0 
None 
history of a prior attack of paralytic poliomyelitis. They were chosen because 
it was predicted that neutralizing antibody of Lansing type would be present, 
since this antibody is distributed among the population in a manner that in- 
creases with age, until adolescence or adulthood, when almost all individuals 
have it (11-13).  As expected, all had a high level of Lansing-type neutralizing 
antibody;  there  were  fewer  CF  positives, and  at  a  lower  level, than  were 
found among those obtained from poliomyelitis convalescents. 
In another series of experiments (Table VII) the possibility of cross-fixation 
between non-Lansing-type antibody and MEF1 antigen is strengthened. Of 14 
sera,  some of which are  recorded in Table VI,  none had Lansing-type neu- 
tralizing antibody. Furthermore, sera 76, 81,  79, and 72, for which we are in- I34  COMPLEMENT  FIXATION  IN  POLIOMYELITIS 
~lebted to Dr. A. B. Sabin, were obtained from patients having had poliomye- 
litis caused by the Brunhilde strain for this virus, so identified, was not only 
recovered from the patients but their sera exhibited with the passage of time a 
rising titer of neutralizing antibody against their own homologous strain of 
virus  (14).  The results again indicate that cross-fixation may exist between 
non-Lansing type antibody and MEF1  antigen. 
Finally, a table was constructed to summarize the combined results of tests 
on single sera (Table VIII). In this table the results are shown of complement- 
fixation and neutralization tests on the serum obtained from 35 poliomyelitis 
convalescents and from 41  individuals having no history of poliomyelitis. Al- 
though the different groups of sera are small, the data in Table VIII point to 
TABLE  VIII 
Summary of Complement-Fixation and Neutralization Tests 
Diagnosis and 
No. of cases 
Poliomyelitis 
35 
Normal 
41 
Neutralization  test,  Lansing virus 
+ 
22 
17 
19 
Complement-fixation teat, 
MEF1 antigen 
10 
16 
Neutralization index of 50 or more =  +;  of 10-49 =  -4-; complement-fixation test, positive 
serum dilution of 1:8 or higher  =  +;  of 1:2 or 1:4  =  =t=. 
the fact that poliomyelitis patients with positive and questionable neutralizing 
antibody against Lansing virus had a positive complement fixation in a  high 
proportion of instances (13 of 18);  and of the remaining 17 with no Lansing- 
neutralizing antibody 8 had definite fixation, 7 slight fixation, and 2 none. The 
greater number of positive complement fixations with the sera of apparently 
normal persons, occurred in those in which Lansing-neutralizing antibody was 
present  (6 of 22).  In  the absence of Lansing-neutralizing antibody, only oc- 
casionally (1  of  19)  did a  positive fixation appear.  To summarize,  21  of 35 
poliomyelitis cases, or 60 per cent, exhibited fixation in dilution of 1 : 8 or higher, 
while 7 of 41 normal individuals, or 17 per cent, had a similar titer of comple- 
ment-fixing antibody; the latter group comprised chiefly adults who harbored 
Lansing-type neutralizing antibody. 
DISCUSSION 
Attempts to develop a complement-fixation antigen with Lansing-type virus 
have been reported previously by Loring, Raffel, and Anderson (15). Through J. CASALS, P. K. OLITSKY, AND  R. O. ANSLOW  135 
the use of a concentrated, purified preparation positive results with rat, monkey, 
and  human sera were obtained but a certain degree of non-specificity was ap- 
parent in some of their results. In our laboratory previous attempts throughout 
several years consistently failed. The reason for lack of success was believed to 
be that antigenic substance was not present in the preparations in sufficient 
concentration and hence it was assumed that to detect a reaction, antigens of 
a higher potency had to be prepared. Two possibilities were considered: (1)  to 
increase the amount of antigen in the tissues and (2) to resuspend the tissues in a 
smaller volume of diluent than heretofore had been used. It was thought that 
these two conditions might be produced simultaneously in newborn mice. 
It was known  (16)  that by passage of Japanese B and Western equine en- 
cephalitis viruses in newborn mice an increase of pathogenicity and a  higher 
level of complement fixation could be obtained from their CNS tissues. It had 
also been found that such tissues could be emulsified in a  smaller volume of 
diluent  than  those of adults,  yielding an extract which was  not anticomple- 
mentary. Thus, adult mouse CNS tissue (6) could be readily resuspended in 3 
volumes of diluent but not in less,  while newborn mouse CNS tissue could be 
emulsified in  only  1 volume of diluent,  without introducing an  anticomple- 
mentary  effect. This  higher concentration can  be explained perhaps  on  the 
basis of the chemical composition of the CNS  tissues of adult and newborn 
mice.  Folch  (17)  found  that  the  brain  tissue  of 4-day-old mice  contained: 
water, 87.8 per cent; proteins, 8.7 per cent; and total lipids, 3.5 per cent. Most 
of  the  lipids  were  phosphatides;  no  cerebrosides were  present.  In  contrast, 
adult mouse brain contained: water, 78.1 per cent; proteins, 10.6 per cent; and 
lipids, 11.3 per cent. Since less solids, particularly less lipids, were present in the 
newborn mouse brain tissue, it was to be expected that with respect to the wet 
weight of the original tissue more concentrated extracts having no anticom- 
plementary effect could  be  prepared.  As  the  tests  reported  here show,  this 
proved to be the case. 
It is questionable whether the MEF1  strain,  once adapted to the newborn 
mouse (1), has resulted in an increase in its infectivity nor is the cause known 
which underlies the correlation between the adaptation  of the MEF1  strain 
and the development of a potent antigen. Newborn mouse tissue, however, is 
apparently essential  since  the  adapted  virus when passaged  in  adult  mouse 
cerebral tissue failed to yield an effective antigen.  Investigations are now in 
progress to determine whether the use of adapted virus as a complement-fixing 
antigen is based on qualitative or quantitative changes in the virus. 
As reported in the present paper titers of antigens have been low, the latter 
can be diluted only 1 : 2 or 1:4 if they are still to be effective. Attempts are being 
made to increase the titers by passage of the adapted virus in other strains of 
mice. Already, by using  wild mice, a  strain being propagated  by Dr.  H.  A. 
Schneider of this Institute, complement-fixing antigens have been obtained with 
titers of 1:8 and 1 : 16 respectively. If this apparently significant finding proves 136  COMPLEMENT  FIXATION IN POLIOMYELITIS 
generally true, antigens can be prepared in wild mice which will have a binding 
power such as characterizes the encephalitis-virus antigens, now established as 
wholly reliable and useful for specific diagnosis of infections (6, 8). By the use 
of such  potent MEF1  antigens,  the  1:2  and  1:4  reactions recorded  in  the 
tables might conceivably have been extended to a higher level with result in 
findings thus definitely positive. 
In the present work a specific complement-fixation reaction has been demon- 
strated between antibody in the serum of man and of some lower animals and 
the MEF1  (a Lansing-type virus) antigen.  Now the problem is whether such 
an antigen will detect only type-specific antibody or will be inclusive, that is to 
say, react with antibody against other types of the poliomyelitis virus. The 
fact that the sera were positive which were obtained from patients who had 
no Lansing-neutralizing antibody but from whom a  Brunhilde strain was iso- 
lated, proving to be related to their illness,  seems to indicate that a  cross-re- 
action may have existed between the Lansing and the Brunhilde types. This 
aspect of the problem, however, requires further study before a  definite con- 
clusion can be reached, and further study is also needed to discover whether 
the  complement-fixation test  can be  applied practically to  the  diagnosis of 
poliomyelitis. The development of the antibody with passage of time, its per- 
sistence, its occurrence in different clinical types of the disease, and the condi- 
tions under which a rise in titer can be demonstrated in paired sera, acute and 
convalescent, are also problems still under investigation. 
It is of interest that sera from normal individuals had complement-fixing 
antibody in 7 of 41  instances. The significance of these positives has not yet 
been determined; it is thought, however, that in 6 positive cases of 22 normal 
persons in whom neutralizing antibody of the Lansing-type was present,  the 
fixation antibody may indicate a  recent  subclinical infection, or,  possibly, a 
repeated infection with virus of this type. Of the  19 individuals that had no 
neutralizing antibody against the Lansing virus, only one was positive and 2 
exhibited low or questionable reactions. It is assumed that these individuals 
had not been infected with the Lansing virus and that these positive reactions 
point to subclinical infection with virus of another type. 
CONCLUSIONS 
A  complement-fixing  antigen has been developed, using as source of ma- 
terial  CNS tissue  from newborn mice  infected  with  the  newborn mouse-adapted 
strain  of the Lansing type, MEFI  virus.  With this  antigen,  specific  reactions 
have been obtained with sera  from mice,  cotton rats,  and monkeys immunized 
with the  Lansing-type virus,  and from monkeys and chimpanzees convalescent 
from infection  with this  virus. 
Twenty-one  of 35 human  sera  obtained from individuals  convalescent from 
poliomyelitis  were positive  and 6 of  22 from apparently normal persons having J.  CASALS, P.  K.  OLITSKY, AND R.  O.  ANSLOW  137 
Lansing-neutralizing antibody, while this held true for only 1 of 19 from those 
having  no  Lansing-neutralizing antibody. 
The fact that positive results were found in sera from patients having an 
infection with poliomyelitis virus of the Brunhilde type and at the same time 
no Lansing-neutralizing antibody brings up the possibility of the existence of 
a  cross-reaction in complement fixation between the  two  types. 
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